Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

October 31, 2011

Conditions
Advanced or Metastatic Solid Tumors
Interventions
DRUG

NMS-1286937

Single Arm, dose escalation study. No. of cycles: until progression or unacceptable toxicity develops.

Trial Locations (1)

85258

Arizona TGen Clinical Research Services at Scottsdale Heathcare, Scottsdale

Sponsors
All Listed Sponsors
lead

Nerviano Medical Sciences

INDUSTRY

NCT01014429 - Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter